0.50 USD
↘ 0.19 (27.30%)AT CLOSE (11:59 AM EDT)
Context Therapeutics Inc. Common Stock
CNTXNASDAQ • USD
0.50
↘ 0.01 (1.79%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
0.50
↘ 0.01 (1.79%)
Market: CLOSED
CNTX is currently priced at $0.51. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Aug 6, 2026.
Open?$0.50
High?$0.54
Low?$0.49
Prev. Close?$0.69
Volume?4.3M
Avg. Volume?2.9M
VWAP?$0.51
Rel. Volume?1.50x
Bid / Ask
Bid?$0.43 × 100
Ask?$0.58 × 100
Spread?$0.15
Midpoint?$0.51
Valuation & Ratios
Market Cap?63.4M
Shares Out?91.9M
Float?69.3M
Float %?75.4%
P/E Ratio?N/A
P/B Ratio?1.21
EPS?-$0.44
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
Themes
Employees
15
Market Cap
63.7M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-10-20
Address
2001 MARKET STREET
PHILADELPHIA, PA 19103
Phone: 267-225-7416
PHILADELPHIA, PA 19103
Phone: 267-225-7416
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?11
Momentum?23
Short Sent.?36
Piotroski F-Score?0/9Weak
Altman Z-Score?1.01Distress
Confidence?57%Low
Short InterestElevated
Short % of Float?9.57%Elevated
Short Interest?6.6M
Days to Cover?1.8
Free Float69.3M
Avg Daily Volume3.7M
Settlement Date2026-07-15
Financial Health
Current Ratio?8.96Strong
Quick Ratio?8.96Strong
Cash Ratio?8.34Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.21CHEAP▾
Peers100
S&P93
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.2CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-77.1%WEAK▾
S&P3
ROA?-68.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-32823631
Enterprise Value?$8.9M
Fundamentals ratios updated end of day